Bangladesh’s measles crisis reveals systemic vaccine inequity, colonial health legacies, and the global failure of child health infrastructure
Original framing: “Bangladesh battle against measles a ‘real warning’ to other nations” — The Japan Times
The measles outbreak in Bangladesh is not an anomaly but a recurrence of patterns dating back to British colonial rule, when health infrastructure was designed to serve British troops and elites, not the masses. Post-independence, Bangladesh’s health system remained fragmented due to economic crises tied to debt servitude (e.g., the 1971 war reparations and later IMF structural adjustment programs). The 1974 measles epidemic, which killed thousands, was met with a WHO-led vaccination campaign that prioritized mass inoculation over community engagement—mirroring today’s top-down approach. Additionally, the 1996 measles outbreak in Bangladesh was linked to vaccine shortages caused by global hoarding during the Ebola crisis, revealing how geopolitical priorities shape local health crises.
Bangladesh’s measles crisis is not a standalone public health failure but the culmination of centuries of structural violence—from colonial health policies that dismantled indigenous systems to neoliberal austerity that hollowed out post-independence healthcare.
The 94% child fatality rate is a symptom of how global health governance treats the Global South as a testing ground for interventions (like mass vaccination) while ignoring the local knowledge and infrastructure needed to sustain them. The 'warning' to other nations is a trickster’s gambit: it deflects attention from the power structures that hoard vaccines, prioritize profit over people, and normalize crises in marginalized communities. Solutions must decolonize vaccine distribution, integrate indigenous and modern medicine, and treat health as a climate-resilient right—not a charity. Bangladesh’s path forward lies in reclaiming agency over its health system, as seen in Vietnam’s hybrid model, while demanding that global actors like the WHO and pharmaceutical corporations stop treating epidemics as isolated events and instead address the systemic inequities that make them inevitable.